Neurosurgery, 2020 · DOI: 10.1093/neuros/nyz499 · Published: December 3, 2019
Degenerative cervical myelopathy (DCM) involves spinal cord compression, which causes neurological decline. Neurological impairment in DCM is variable and can involve complex upper limb dysfunction including loss of manual dexterity, hyperreflexia, focal weakness, and sensory impairment. The modified Japanese Orthopaedic Association (mJOA) score relies on the patients’ subjective perceptions, whereas existing objective measures such as strength and sensory testing do not capture subtle changes in dexterity and function. The GRASSP-M is an objective tool designed to characterize patients’ functional impairment related to the upper limb, which proves useful to diagnose and quantify mild dysfunction, monitor patients for deterioration, and help determine when patients should be treated surgically.
The GRASSP-M allows for earlier and more accurate diagnosis of DCM by objectively quantifying hand impairment.
The tool facilitates better monitoring of disease progression and deterioration in patients with DCM.
The GRASSP-M aids in treatment planning by helping to determine when patients should be treated surgically.